ARM Trademark

Trademark Overview


On Tuesday, August 1, 2023, a trademark application was filed for ARM with the United States Patent and Trademark Office. The USPTO has given the ARM trademark a serial number of 98112130. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 1, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The ARM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, namely, multifunctional molecules that promote recruitment of antibodies to disease cells or organisms, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, cancers, infectious diseases, and neurological disorders

Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
arm

General Information


Serial Number98112130
Word MarkARM
Filing DateTuesday, August 1, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 6, 2024

Trademark Statements


Goods and ServicesPharmaceutical products, namely, multifunctional molecules that promote recruitment of antibodies to disease cells or organisms, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, cancers, infectious diseases, and neurological disorders
Goods and ServicesDiscovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Trademark Events


Event DateEvent Description
Friday, August 4, 2023NEW APPLICATION ENTERED
Wednesday, August 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 23, 2023ASSIGNED TO EXAMINER
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, December 15, 2023ASSIGNED TO EXAMINER
Monday, February 12, 2024ASSIGNED TO EXAMINER
Friday, February 23, 2024NON-FINAL ACTION WRITTEN
Friday, February 23, 2024NON-FINAL ACTION E-MAILED
Friday, February 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 6, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 6, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 1, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER